Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T C Merigan

Showing results (111-120 of 366) with videos related to

Pageof 37
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1986
Regulation of guinea-pig immune functions by interleukin 2: critical role of natural killer activity in acute HSV-2 genital infectionA Weinberg, T Y Basham, T C Merigan
AIDS (London, England)|July 9, 1999
Highly drug-resistant HIV-1 clinical isolates are cross-resistant to many antiretroviral compounds in current clinical developmentS Palmer, R W Shafer, T C Merigan
Journal of Clinical Microbiology|January 1, 1995
Quantitative analysis of syncytium-inducing and non-syncytium-inducing virus in patients infected with human immunodeficiency virus type 1R W Shafer, E Aguiniga, T C Merigan
Nature|November 9, 1973
Suppression of mouse antibody producing spleen cells by various interferon preparationsT J Chester, K Paucker, T C Merigan
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|November 1, 1971
Inhibition of radiogenic lymphoma development in mice by interferonM Lieberman, T C Merigan, H S Kaplan
Intervirology|January 1, 1978
Factors affecting the interferon sensitivity of human cytomegalovirusA R Holmes, L Rasmussen, T C Merigan
Cellular Immunology|October 1, 1978
Time and dosage dependence of immunoenhancement by murine type II interferon preparationsG Sonnenfeld, A D Mandel, T C Merigan
Vaccine|January 1, 1992
Liposome-formulated interleukin-2 as an adjuvant of recombinant HSV glycoprotein gD for the treatment of recurrent genital HSV-2 in guinea-pigsR J Ho, R L Burke, T C Merigan
The Journal of Infectious Diseases|March 1, 1997
A novel approach to assessing the drug susceptibility and replication of human immunodeficiency virus type 1 isolatesR M Jellinger, R W Shafer, T C Merigan
Infection and Immunity|July 1, 1970
Potentiating Effect of Freund's Adjuvant on Interferon Production by Endotoxin or Poly rI*Poly rCE De Clercq, M R Nuwer, T C Merigan
Pageof 37

Showing results (111-120 of 366) with videos related to

Sort By:
Pageof 37
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1986
Regulation of guinea-pig immune functions by interleukin 2: critical role of natural killer activity in acute HSV-2 genital infectionA Weinberg, T Y Basham, T C Merigan
AIDS (London, England)|July 9, 1999
Highly drug-resistant HIV-1 clinical isolates are cross-resistant to many antiretroviral compounds in current clinical developmentS Palmer, R W Shafer, T C Merigan
Journal of Clinical Microbiology|January 1, 1995
Quantitative analysis of syncytium-inducing and non-syncytium-inducing virus in patients infected with human immunodeficiency virus type 1R W Shafer, E Aguiniga, T C Merigan
Nature|November 9, 1973
Suppression of mouse antibody producing spleen cells by various interferon preparationsT J Chester, K Paucker, T C Merigan
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|November 1, 1971
Inhibition of radiogenic lymphoma development in mice by interferonM Lieberman, T C Merigan, H S Kaplan
Intervirology|January 1, 1978
Factors affecting the interferon sensitivity of human cytomegalovirusA R Holmes, L Rasmussen, T C Merigan
Cellular Immunology|October 1, 1978
Time and dosage dependence of immunoenhancement by murine type II interferon preparationsG Sonnenfeld, A D Mandel, T C Merigan
Vaccine|January 1, 1992
Liposome-formulated interleukin-2 as an adjuvant of recombinant HSV glycoprotein gD for the treatment of recurrent genital HSV-2 in guinea-pigsR J Ho, R L Burke, T C Merigan
The Journal of Infectious Diseases|March 1, 1997
A novel approach to assessing the drug susceptibility and replication of human immunodeficiency virus type 1 isolatesR M Jellinger, R W Shafer, T C Merigan
Infection and Immunity|July 1, 1970
Potentiating Effect of Freund's Adjuvant on Interferon Production by Endotoxin or Poly rI*Poly rCE De Clercq, M R Nuwer, T C Merigan
Pageof 37